Hi there, we see you're using OS, why not try our app?
Download
Skip to main content
1

10 July: We have enough stock to supply to your needs

 

See our blood stock levels

COVID-19

Clinical guidelines

Haematopoietic Stem Cell Transplantation (HSCT)

The National Institute for Health and Care Excellence (NICE) have provided some guidance to maximise the safety of patients requiring HSCT while protecting staff from infection. 

(published 2 April)

Thrombotic thrombocytopenic Purpura (TTP)

Prof. Marie Scully has provided an update on behalf of the TTP Network advising of the risks associated with COVID-19 in TTP patients

(published 2 April)

Sickle Cell and Thalassaemia

The Haemoglobinopathy Co-ordinating Centres have developed advice for the management of COVID-19 in patients with Sickle Cell Disease and Thalassaemia. 

BSH COVID-19 updates

(published 23 March)


Operational updates

Bristol unit temporary relocation from 9 April 2020

Please note our Therapeutic Apheresis Services unit address in Bristol has temporarily changed to: Level 5 Outpatients (location D502) Bristol Haematology and Oncology Centre, Horfield Road, Bristol BS2 8ED.

Please advise patients to use the main entrance to the Haematology and Oncology Centre as usual to attend appointments but to take the lift to Level 5. Please assume we are on level 5 until this website is otherwise updated.

(published 9 April)

Patient website

Our patient-facing website is being regularly updated (published 2 April).

Birmingham unit temporary relocation from 31 March 2020

For patients/ visitors to the Therapeutic Apheresis Services (TAS) unit in Birmingham, please note we are currently located at the Birmingham Treatment Centre, on the ground floor, at the old Oncology department consulting room 3.

Alternatively, patients / visitors can attend the Sickle Cell and Thalassemia Centre at City Hospital on the first floor as usual and staff will direct you to the TAS Unit from there. Please assume the unit is located on the ground floor until this website is otherwise updated.

(published 31 March)

Risk mitigation

Our services are currently operating as per national guidance (such as Public Health England and NICE) and we are regularly reviewing operations with internal and external stakeholders. We are currently undertaking the following measures to ensure risks are minimised:

  • If you wish to refer a patient positive for COVID-19, please discuss this with your TAS unit
  • All staff members with symptoms of a new continuous cough or high temperature should stay at home and self-isolate
  • TAS units should be kept up to date with your local Trust arrangements for management of the coronavirus 

(published 23 March)